VERZONI, ELENA
VERZONI, ELENA
Universita' degli Studi di MILANO
Biomarker-driven immunotherapy for precision medicine in prostate cancer
2022 A. Ottini, P. Sepe, T. Beninato, M. Claps, V. Guadalupi, E. Verzoni, P. Giannatempo, G. Baciarello, F. De Braud, G. Procopio
Butterfly and renal cell cancer : Out of chaos comes order
2014 G. Procopio, E. Verzoni, F. De Braud
Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21)
2022 A. Mennitto, E. Zattarin, M. Di Maio, D. Bimbatti, U. De Giorgi, S. Buti, D. Santini, C. Casadei, M. Soraru, C. Messina, C. Mucciarini, G. Di Lorenzo, G. Roviello, C. Buttigliero, M. Stellato, P. Sepe, M. Claps, V. Guadalupi, A. Ottini, S. Pignata, F.G. De Braud, E. Verzoni, G. Procopio
Cabozantinib in the treatment of advanced renal cell carcinoma : Design, development, and potential place in the therapy
2016 P. Grassi, E. Verzoni, R. Ratta, A. Mennitto, F. de Braud, G. Procopio
Clinical experience with temsirolimus in the treatment of advanced renal cell carcinoma
2015 E. Zanardi, E. Verzoni, P. Grassi, A. Necchi, P. Giannatempo, D. Raggi, F. De Braud, G. Procopio
Clinical impact of Pancreatic metastases from renal cell carcinoma : A multicenter retrospective analysis
2016 P. Grassi, L. Doucet, P. Giglione, V. Grünwald, B. Melichar, L. Galli, U. De Giorgi, R. Sabbatini, C. Ortega, M. Santoni, A. Bamias, E. Verzoni, L. Derosa, H. Studentova, M. Pacifici, J. Coppa, V. Mazzaferro, F. De Braud, C. Porta, B. Escudier, G. Procopio
Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?
2017 P. Grassi, E. Verzoni, R. Ratta, L. Porcu, M. Prisciandaro, A. Mennitto, G. Calareso, F. de Braud, G. Procopio
Everolimus and temsirolimus are not the same second-line in metastatic renal cell carcinoma : a systematic review and meta-analysis of literature data
2015 R. Iacovelli, M. Santoni, E. Verzoni, P. Grassi, I. Testa, F. De Braud, S. Cascinu, G. Procopio
First line treatment of metastatic renal cell carcinoma : two standards with different toxicity profile
2014 R. Iacovelli, E. Verzoni, F. De Braud, G. Procopio
From biology to clinical experience : evolution in the knowledge of neuroendocrine tumours
2009 E. Bajetta, G. Procopio, S. Pusceddu, F. Pietrantonio, M. Milione, M. Maccauro, E. Verzoni, V. Guadalupi, M. Platania
Immunotherapy advances in uro-genital malignancies
2016 R. Ratta, R. Zappasodi, D. Raggi, P. Grassi, E. Verzoni, A. Necchi, M. Di Nicola, R. Salvioni, F. de Braud, G. Procopio
Inhibition of the VEGF/VEGFR pathway improves survival in advanced kidney cancer : a systematic review and meta-analysis
2015 R. Iacovelli, C.N. Sternberg, C. Porta, E. Verzoni, F. de Braud, B. Escudier, G. Procopio
Integrated transcriptional-phenotypic analysis captures systemic immunomodulation following antiangiogenic therapy in renal cell carcinoma patients
2021 D. Rinchai, E. Verzoni, V. Huber, A. Cova, P. Squarcina, L. De Cecco, F. de Braud, R. Ratta, M. Dugo, L. Lalli, V. Vallacchi, M. Rodolfo, J. Roelands, C. Castelli, D. Chaussabel, G. Procopio, D. Bedognetti, L. Rivoltini
Management of advanced genitourinary tumors
2012 F. Pietrantonio, P. Biondani, E. Verzoni, G. Procopio
Outcome of Patients with Renal Cell Carcinoma and Multiple Glandular Metastases Treated with Targeted Agents
2017 P. Grassi, L. Doucet, P. Giglione, V. Grünwald, B. Melichar, L. Galli, U. De Giorgi, R. Sabbatini, C. Ortega, M. Santoni, A. Bamias, E. Verzoni, L. Derosa, H. Studentova, L. Porcu, F. De Braud, C. Porta, G. Procopio
Patient approach in advanced/metastatic renal cell carcinoma : focus on the elderly population and treatment-related toxicity
2013 E. Verzoni, F. de Braud, F. Fabiani, P. Grassi, I. Testa, G. Procopio
Prognostic reclassification of patients with intermediate-risk metastatic germ cell tumors : implications for clinical practice, trial design, and molecular interrogation
2015 D. Raggi, L. Mariani, P. Giannatempo, S. Lo Vullo, D. Giardiello, N. Nicolai, L. Piva, D. Biasoni, M. Catanzaro, T. Torelli, S. Stagni, M. Maffezzini, G. Calareso, M. Magni, M. Di Nicola, E. Verzoni, P. Grassi, G. Procopio, F. De Braud, G. Pizzocaro, R. Salvioni, A. Necchi
Prognostic role of pancreatic metastases from renal cell carcinoma : Results from an Italian center
2013 P. Grassi, E. Verzoni, L. Mariani, F. De Braud, J. Coppa, V. Mazzaferro, G. Procopio
Rationale and protocol of RESORT, a randomized, open-label, multicenter phase II study to evaluate the efficacy of sorafenib in patients with advanced renal cell carcinoma after radical resection of the metastases
2014 G. Procopio, E. Verzoni, P. Biondani, P. Grassi, I. Testa, E. Garanzini, F. de Braud
Rationale and protocol of SOAP : A phase II study to evaluate the efficacy of Sorafenib as second-line treatment after pazopanib in patients with advanced renal cell carcinoma
2014 R. Iacovelli, E. Verzoni, P. Grassi, A. Farcomeni, F. De Braud, G. Procopio